Nasal administration composition for treating neurological and neurodegenerative diseases and disorders

摘要

PROBLEM TO BE SOLVED: To generally relate to a nasal administration pharmaceutical composition. In particular, the present invention is directed to sustained and enhanced delivery of pharmaceutical agents across the nasal mucosa for systemic drug delivery. A sustained release nasal administration aqueous preparation containing ribastigmine or a pharmaceutically acceptable salt thereof, a pH adjuster, and a thickener, wherein the pH of the preparation is in the range of about 3 to 6. Release nasal administration aqueous preparation. [Selection diagram] None